Medical research

TGA dismisses bid to make contraceptive pill available over the counter in Australia

Two applications were made to amend poisons legislation so that the pill would not need ongoing prescriptions from doctor Download the free Guardian app; get our morning email briefing A push to make the contraceptive pill available over the counter has been dismissed by Australia’s drugs regulator. In an interim decision, now open for further …

TGA dismisses bid to make contraceptive pill available over the counter in Australia Read More »

Local Covid vaccines fill gap as UN Covax scheme misses target

India, Egypt and Cuba among first states to develop and make their own vaccines as Covax falls behind Developing countries are increasingly turning to homegrown Covid vaccinations as the UN-backed Covax programme falls behind. While western countries roll out booster jabs to their own populations, Covax, which was set up by UN agencies, governments and …

Local Covid vaccines fill gap as UN Covax scheme misses target Read More »

WHO endorses use of world’s first malaria vaccine in Africa

World Health Organization’s director general hails ‘historic day’ in fight against parasitic disease The World Health Organization has recommended the widespread rollout of the first malaria vaccine, in a move experts hope could save tens of thousands of children’s lives each year across Africa. Hailing “an historic day”, the WHO’s director general, Dr Tedros Adhanom …

WHO endorses use of world’s first malaria vaccine in Africa Read More »

Henrietta Lacks’ estate sues drug company that sold her cells

Lacks’s estate is asking Thermo Fisher to pay back the full profits gained over 70 years of using her cells without consent The estate of Henrietta Lacks sued a pharmaceutical company on Monday, accusing it of selling cells that doctors at Johns Hopkins hospital took in 1951 without her knowledge or consent. The cells taken …

Henrietta Lacks’ estate sues drug company that sold her cells Read More »

Coronavirus treatments: the potential ‘game-changers’ in development

After positive clinical trials for antiviral drug Molnupiravir, it joins other medicines that have shown promise Coronavirus – latest updates See all our coronavirus coverage The first clinical trial results showing a positive effect for a pill that can be taken at home has been hailed as a potential gamechanger that could provide a new …

Coronavirus treatments: the potential ‘game-changers’ in development Read More »

Covid antiviral pill halves hospitalisations and deaths, maker says

If approved, Merck’s drug would be first simple oral medication shown to be effective against coronavirus Coronavirus – latest updates See all our coronavirus coverage The first pill to treat coronavirus could be available within months after it was found to cut hospitalisations and deaths by half. If approved, the antiviral drug would be the …

Covid antiviral pill halves hospitalisations and deaths, maker says Read More »

Ministers told to bar EU from UK trial data in vaccines row

England’s deputy medical chief asked for data to be withheld unless British vaccine guinea pigs allowed to travel abroad • Coronavirus – latest updates• See all our coronavirus coverage England’s deputy chief medical officer asked ministers to withhold all UK clinical trial data from the EU if European countries continued to deny entry to British …

Ministers told to bar EU from UK trial data in vaccines row Read More »

GSK teams with King’s College to use AI to fight cancer

Artificial intelligence will be used to develop personalised treatments while investigating role of genetics The pharmaceuticals firm GSK has struck a five-year partnership with King’s College London to use artificial intelligence to develop personalised treatments for cancer by investigating the role played by genetics in the disease. The tie-up, which involves 10 of the drug …

GSK teams with King’s College to use AI to fight cancer Read More »

BioNTech to seek approval for Covid jabs for younger children

Company behind Pfizer vaccine expected to file results of trial of five- to 11-year-olds with regulator soon Coronavirus – latest updates See all our coronavirus coverage The German company BioNTech, which developed the Pfizer vaccine, expects to seek approval from regulators for Covid jabs suited for younger children as early as mid-October, its founders have …

BioNTech to seek approval for Covid jabs for younger children Read More »

Pfizer accused of holding Brazil ‘to ransom’ over vaccine contract demands

Leaked supply document reveals clauses to protect US pharma company from legal action in the event of serious side-effects Coronavirus – latest updates See all our coronavirus coverage Pfizer has been accused of holding Brazil “to ransom” over demands to shield itself from possible vaccine side-effect lawsuits in its contract to supply the country with …

Pfizer accused of holding Brazil ‘to ransom’ over vaccine contract demands Read More »

UK approves rollout of ‘first of its kind’ Covid antibody treatment

Ronapreve can be used to treat symptoms of acute infection after successful clinical trials Coronavirus – latest updates See all our coronavirus coverage The medicines regulator has approved use of the first treatment in the UK using artificial antibodies to prevent and fight Covid-19. The health secretary, Sajid Javid, said approval of the first drug …

UK approves rollout of ‘first of its kind’ Covid antibody treatment Read More »

Breast cancer drug approved for NHS after maker agrees discount

Reversal of earlier rejection by Nice of abemaciclib – known as Verzenios – is welcomed by campaigners A breast cancer drug that was rejected for routine NHS use in England earlier this year has now been recommended by health officials after a discount was agreed with the manufacturer. The decision has been described as “fantastic …

Breast cancer drug approved for NHS after maker agrees discount Read More »

UK orders extra Covid vaccines for autumn 2022 booster campaign

Pfizer reportedly asked to supply 35m more doses, with final go-ahead for this year’s programme still awaited Coronavirus – latest updates See all our coronavirus coverage Ministers have started ordering vaccines for a booster campaign in autumn 2022, with Pfizer reportedly being asked to supply the UK with a further 35m doses. The government has …

UK orders extra Covid vaccines for autumn 2022 booster campaign Read More »

Covid drug could help reduce heavy menstrual bleeding

Trial suggests anti-inflammatory dexamethasone may offer welcome alternative to intra-uterine system Researchers hope a steroid that shot to prominence during the Covid pandemic may help reduce blood loss in those who experience heavy periods. The cheap anti-inflammatory dexamethasone was discovered to improve survival rates among patients critically ill with Covid. It is also used for …

Covid drug could help reduce heavy menstrual bleeding Read More »

As Delta spreads, Pfizer and Moderna get set for a booster shot to profits

The firms are already taking the lion’s share of earnings from the market, as this week’s results will show Praised for preventing hundreds of thousands of deaths and allowing a return to more normal life, Covid vaccines will also substantially benefit some pharmaceutical companies. In June, analysts estimated the global market for the vaccines could …

As Delta spreads, Pfizer and Moderna get set for a booster shot to profits Read More »

AstraZeneca sales of Covid vaccine triple to $1.2bn in first half of 2021

Not-for-profit pledge sees British firm’s sales revenue fall significantly short of US rival Pfizer Coronavirus – latest updates See all our coronavirus coverage AstraZeneca’s Covid-19 vaccine has brought in $1.2bn (£900m) in the first half of this year, with sales tripling in the second quarter from the first – but its earnings remained significantly below …

AstraZeneca sales of Covid vaccine triple to $1.2bn in first half of 2021 Read More »

Oxford drugs firm gains $1.5m Gates grant for Covid-19 therapy

Exclusive: Exscientia to use AI in proposed fast-track development of ‘low-cost’ pill for Sars viruses Coronavirus – latest updates See all our coronavirus coverage Exscientia, an Oxford-based firm that uses artificial intelligence to develop medicines, has won a $1.5m grant from the Bill & Melinda Gates Foundation to create a Covid-19 treatment that also works …

Oxford drugs firm gains $1.5m Gates grant for Covid-19 therapy Read More »

Moderna, Pfizer or AstraZeneca? The ridiculous, diverting rise of vaccine envy

Casual vaccine chat is today’s only form of small talk, so it’s not surprising it would take a lightheartedly tribal turn. Ultimately, of course, gratitude is at the heart of the conversation Last week, I had cause to go searching for images of men getting vaccinated (it’s not a fetish – it was for work) …

Moderna, Pfizer or AstraZeneca? The ridiculous, diverting rise of vaccine envy Read More »

Drop Covid vaccine patent rules to save lives in world’s poorest countries, Britain and Germany told

G7 summit hears move would slash the cost of jabs and accelerate the rollout of programmes across the developing world Britain and Germany were last night under intense pressure to drop their resistance to proposals that would slash the cost of Covid-19 vaccines, following accusations that an agreement at the G7 summit to fund a …

Drop Covid vaccine patent rules to save lives in world’s poorest countries, Britain and Germany told Read More »

Ronald Cresswell obituary

Pharmaceutical researcher with a flair for business who brought a string of vital drugs to market In 1960 the chemist Ronald Cresswell, who has died aged 86, had a lucky break. As a result of travelling from Glasgow to take up a post in New York he attended a conference of the American Chemical Society, …

Ronald Cresswell obituary Read More »

More research funding needed to avoid drug-resistant pandemic, warns report

Smaller firms are developing most antibiotics targeting superbugs but often at risk of bankruptcy Small drugmakers and biotech firms that are developing the bulk of new antibiotics need far more financial support, according to a new report, which warned that without these life-saving medicines there could be a pandemic of drug-resistant infections, worse than Covid-19. …

More research funding needed to avoid drug-resistant pandemic, warns report Read More »

UK pharmaceutical firm Ventura agrees to £958m takeover deal

Private equity firm Carlyle Group to buy company that is developing inhaled treatment for Covid-19 Coronavirus – latest updates See all our coronavirus coverage The British pharmaceutical company Vectura Group, which is developing a pioneering inhaled treatment for Covid-19, has agreed a £958m takeover by Carlyle Group as it looks set to become the latest …

UK pharmaceutical firm Ventura agrees to £958m takeover deal Read More »

Delay in giving second jabs of Pfizer vaccine improves immunity

Study finds antibodies against Sars-CoV-2 three-and-a-half times higher in people vaccinated again after 12 weeks rather than three Coronavirus – latest updates See all our coronavirus coverage The UK’s decision to delay second doses of coronavirus vaccines has received fresh support from research on the over-80s which found that giving the Pfizer/BioNTech booster after 12 …

Delay in giving second jabs of Pfizer vaccine improves immunity Read More »

EU wants to mass produce three ‘course-changing’ Covid drugs from October

Health commissioner says plan is to reduce hospitalisation and tackle long-term impact of Covid Coronavirus – latest updates See all our coronavirus coverage Three Covid medicines with the potential to “change the course” of the pandemic will be authorised for mass production and use in the EU by October under a European Commission plan. Stella …

EU wants to mass produce three ‘course-changing’ Covid drugs from October Read More »

Investors flock to life sciences as UK sector breaks funding record

Covid crisis spurs growing interest in drugmakers, diagnostics and medical equipment firms UK drugmakers, diagnostics, medical equipment and other life sciences companies have raised £10.6bn from private funding rounds and stock market flotations in the first three months of the year, more than half of last year’s record total, according to a report. Last year, …

Investors flock to life sciences as UK sector breaks funding record Read More »

Oxford/AstraZeneca Covid vaccine research ‘was 97% publicly funded’

Analysis rebuts claim by Boris Johnson that jab was developed ‘because of greed’ Coronavirus – latest updates See all our coronavirus coverage At least 97% of the funding for the development of the Oxford/AstraZeneca Covid-19 vaccine has been identified as coming from taxpayers or charitable trusts, according to the first attempt to reconstruct who paid …

Oxford/AstraZeneca Covid vaccine research ‘was 97% publicly funded’ Read More »

Will Covid vaccines protect us against new variants? | Julian Tang

New strains such as the South African variant that’s emerged in south London will require constant vigilance as lockdown eases All viruses mutate. They do this to adapt and survive better in their specific host. The virus that causes Covid-19 is no different: it has moved from the animal realm, where it most likely originated …

Will Covid vaccines protect us against new variants? | Julian Tang Read More »

UK strategy of backing several Covid vaccines seems to be paying off

Analysis: buying new and existing technologies ensured alternatives if a vaccine failed or had supply issues Coronavirus – latest updates See all our coronavirus coverage The government has said the decision by Johnson & Johnson to delay the supply of its Covid vaccine to Europe, while the US investigates reports of six cases of unusual …

UK strategy of backing several Covid vaccines seems to be paying off Read More »

Global Covid vaccine rollout threatened by shortage of vital components

Pharmaceutical firms warn of delays to items such as the large bags in which vaccine cells are grown Coronavirus – latest updates See all our coronavirus coverage Vaccine-makers around the world face shortages of vital components including large plastic growbags, according to the head of the firm that is manufacturing a quarter of the UK’s …

Global Covid vaccine rollout threatened by shortage of vital components Read More »

What does Australia’s new advice on the AstraZeneca Covid vaccine mean and what is the risk?

Experts say the development of blood clots after getting the jab is still an ‘exceedingly rare’ side effect. So what triggered the government’s change in position? Australia’s vaccine rollout is facing a major shake-up after the federal government heeded the advice of its independent health expert advisory body to avoid giving the AstraZeneca vaccine to …

What does Australia’s new advice on the AstraZeneca Covid vaccine mean and what is the risk? Read More »

AstraZeneca jab worry may play into hands of anti-vaxxers, say Tories

Iain Duncan Smith, former leader, and another MP, warn of eroded confidence in vaccine plan after ‘messy’ MHRA advice Coronavirus – latest updates See all our coronavirus coverage A decision to offer people under 30 an alternative vaccine to the AstraZeneca jab has prompted concern that some could shun the injection over fears about its …

AstraZeneca jab worry may play into hands of anti-vaxxers, say Tories Read More »

AstraZeneca Covid vaccine: weighing up the risks and rewards

Despite scientific advice to continue getting the jab, answers about fatal blood clots are urgently needed Coronavirus – latest updates See all our coronavirus coverage Vaccines have side-effects, as do all medicines. Most often, jabs cause sore arms, a headache or a bit of nausea – none of which would be very significant when weighed …

AstraZeneca Covid vaccine: weighing up the risks and rewards Read More »

Blood clot cases ‘could dent faith of young women in AstraZeneca’

Experts urge public to go for inoculations as benefits far outweigh potential complications Coronavirus – latest updates See all our coronavirus coverage Health officials are becoming increasingly worried that younger people will reject Covid jabs as concerns about the AstraZeneca vaccine continue to grow. A total of 30 cases of rare blood clots have been …

Blood clot cases ‘could dent faith of young women in AstraZeneca’ Read More »

Two new vaccines on the way – with more to follow this year

Half of UK adults have had a first jab, and future supplies of millions of doses look assured Coronavirus – latest updates See all our coronavirus coverage Two very different jabs have been responsible for inoculating Britain’s strikingly high number of vaccine recipients – with more than half of the country’s adult population having now …

Two new vaccines on the way – with more to follow this year Read More »

US agency questions AstraZeneca’s Covid vaccine trial data

Drug firm may have provided incomplete view of efficacy data from US trial, says safety monitor Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca vaccine against Covid has been dealt another blow within hours of AstraZeneca posting excellent results from its long-awaited big trial in the US. Questions have been raised in …

US agency questions AstraZeneca’s Covid vaccine trial data Read More »

The Guardian view on pandemic politics: we need cooperation, not confrontation | Editorial

Vaccinating the world is the only way out of Covid, but a mixture of nationalism and protectionism is blocking the exit Covid-19 has proved to be the greatest humanitarian and economic disaster of the century. A reported 2.7 million people have already died from the pathogen. Its recession is estimated to be twice as deep …

The Guardian view on pandemic politics: we need cooperation, not confrontation | Editorial Read More »

Patrick Vallance: the adviser who spoke scientific truth to power

The UK’s chief scientific adviser loves good food, enjoys a Scandi drama – and has been called ‘the richest civil servant in history’ Sir Patrick Vallance spent his 60th birthday at a podium in Downing Street, flanking Boris Johnson. Whatever plans he had were scrapped. Continue reading…

Patrick Vallance: the adviser who spoke scientific truth to power

The UK’s chief scientific adviser loves good food, enjoys a Scandi drama – and has been called ‘the richest civil servant in history’ Sir Patrick Vallance spent his 60th birthday at a podium in Downing Street, flanking Boris Johnson. Whatever plans he had were scrapped. Continue reading…

What price a child’s life? India’s quest to make rare disease drugs affordable

Parents whose only hope was finding foreign sponsorship or a clinical trial are now looking for homegrown breakthroughs For three years, Vidya tried to find the cause of her son’s recurrent fevers and low cognitive development. When she found out, she was devastated. Vineeth, 10, has an incurable illness – mucopolysaccharidosis type 2 – that …

What price a child’s life? India’s quest to make rare disease drugs affordable Read More »

Ireland suspends AstraZeneca Covid vaccine over blood clot concerns

Deployment of Oxford vaccine temporarily deferred after latest reports from Norway Coronavirus – latest updates See all our coronavirus coverage Ireland is suspending use of the Oxford/AstraZeneca vaccine against Covid as a precautionary measure following further reports of blood clots in people who have received it, this time from Norway. The deputy chief medical officer, …

Ireland suspends AstraZeneca Covid vaccine over blood clot concerns Read More »

At AstraZeneca, we know that until everyone is safe from Covid, no one is safe | Pascal Soriot

The scientific community are rising to the challenge, undertaking an unprecedented global health programme Pascal Soriot is the chief executive officer of AstraZeneca Coronavirus – latest updates See all our coronavirus coverage Covid-19 is a virus that knows no boundaries and has inflicted terrible suffering across the world. Now more than ever, we must remember …

At AstraZeneca, we know that until everyone is safe from Covid, no one is safe | Pascal Soriot Read More »

NHS to use world’s most expensive drug to treat spinal muscular atrophy

Zolgensma, which costs £1.79m for one-off treatment, will be available in England this year for the first time The world’s most expensive drug, which treats babies and young children with a rare and often fatal degenerative disorder, will be available this year for the first time on the NHS in England. Zolgensma, which costs £1.79m …

NHS to use world’s most expensive drug to treat spinal muscular atrophy Read More »

From Pfizer to Moderna: who’s making billions from Covid vaccines?

The companies in line for the biggest gains – and the shareholders who have already made fortunes Coronavirus – latest updates See all our coronavirus coverage The arrival of Covid-19 vaccines promises a return to more normal life – and has created a global market worth tens of billions of dollars in annual sales for …

From Pfizer to Moderna: who’s making billions from Covid vaccines? Read More »

Covid: Germany and France under pressure to shift Oxford vaccine

Both countries urged to take action to avoid pile-up of unused AstraZeneca vaccine doses Coronavirus – latest updates See all our coronavirus coverage Authorities in Germany and France are under pressure to come up with creative solutions to shift the AstraZeneca vaccine at higher speed in order to avoid a pile-up of unused doses over …

Covid: Germany and France under pressure to shift Oxford vaccine Read More »

Germany signals AstraZeneca vaccine may be approved for over-65s

Healthcare regulator says it will update recommendations ‘very soon’ in wake of row over jab’s effectiveness in older candidates Coronavirus – latest updates See all our coronavirus coverage Germany could soon authorise the use of the AstraZeneca vaccine for seniors after the head of the country’s vaccination committee said his body’s advice to give the …

Germany signals AstraZeneca vaccine may be approved for over-65s Read More »

German politicians counter AstraZeneca vaccine scepticism with show of support

Oxford Covid vaccine described in German media as ‘shelf warmer’ with only 17% of doses administered so far Coronavirus – latest updates See all our coronavirus coverage Politicians in Germany are stepping out in support of the AstraZeneca vaccine as public scepticism around the Oxford-developed product is threatening to hamper Europe’s Covid-19 immunisation programme. The …

German politicians counter AstraZeneca vaccine scepticism with show of support Read More »

Life savers: the amazing story of the Oxford/AstraZeneca Covid vaccine

A year ago, two scientists began work on the response to a new virus. Now, as their vaccine is being given to millions, they tell of their incredible 12 months Exactly a year ago, Oxford University scientists launched a joint enterprise that is set to have a profound impact on the health of our planet. …

Life savers: the amazing story of the Oxford/AstraZeneca Covid vaccine Read More »

A series of knocks: Oxford/AstraZeneca’s bumpy road to Covid vaccine confidence

From doubts about safety in older people to questions about variants, scientists have faced a battle to convince the public and regulators Coronavirus – latest updates See all our coronavirus coverage The Oxford University/AstraZeneca vaccine against Covid has barely been out of the news from the moment the race to protect the world’s population from …

A series of knocks: Oxford/AstraZeneca’s bumpy road to Covid vaccine confidence Read More »

Oxford Covid vaccine 10% effective against South African variant, study suggests

Small-scale trial of vaccine’s efficacy shows it offers very little protection against mild to moderate infection Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca vaccine offers as little as 10% protection against the Covid variant first seen in South Africa, researchers have suggested. Scientists who conducted a small-scale trial of the vaccine’s …

Oxford Covid vaccine 10% effective against South African variant, study suggests Read More »

Oxford Covid vaccine just as effective against Kent variant, trials suggest

Scientists behind AstraZeneca vaccine say it has similar efficacy against variant as against original Covid Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca coronavirus vaccine is just as effective at fighting the UK variant as it is the original virus, new research suggests. Oxford University researchers who developed the vaccine say it …

Oxford Covid vaccine just as effective against Kent variant, trials suggest Read More »

One Pfizer/BioNTech jab gives ‘90% immunity’ from Covid after 21 days

New analysis runs counter to earlier study which suggested one dose may not give adequate protection Coronavirus – latest updates See all our coronavirus coverage One dose of the Pfizer/BioNTech vaccine gives people about 90% protection from Covid by 21 days, according to an analysis of Israel’s mass vaccination programme. The data analysis, carried out …

One Pfizer/BioNTech jab gives ‘90% immunity’ from Covid after 21 days Read More »

GSK and CureVac sign £132m deal to develop multi-variant Covid vaccine

Companies hope to have next generation of vaccines against emerging variants by next year GlaxoSmithKline and Germany’s CureVac have reached a €150m (£132m) agreement to develop a next generation of Covid-19 vaccines targeting new emerging variants in the pandemic. The two companies said they they plan to work jointly to develop a vaccine that can …

GSK and CureVac sign £132m deal to develop multi-variant Covid vaccine Read More »

Even with vaccines, we still need treatments for Covid. So what works?

Analysis: death rates in intensive care are falling as doctors identify more ways to help those with the disease Coronavirus – latest updates See all our coronavirus coverage Vaccines may have been described as the great escape route from the Covid pandemic – but treatments, which are bringing down death rates, will be needed as …

Even with vaccines, we still need treatments for Covid. So what works? Read More »

UK vaccine strategy ‘paying off’ as latest trials boost stockpiles

Pre-ordering of Janssen and Novavax means Britain has procured 247m successfully trialled jabs Coronavirus – latest updates See all our coronavirus coverage Britain has cemented its status as one of the world’s leading buyers of effective Covid vaccines after two more pharmaceutical companies reported positive trial results – potentially growing the UK stockpile by 90m …

UK vaccine strategy ‘paying off’ as latest trials boost stockpiles Read More »

How effective is the Novavax Covid vaccine and will it work against variants?

Everything you need to know about the trial results for a new coronavirus vaccine Coronavirus – latest updates See all our coronavirus coverage In an interim analysis of a phase 3 clinical trial conducted in the UK, the vaccine has been shown to be nearly 89% effective, with 27% of participants in the trial – …

How effective is the Novavax Covid vaccine and will it work against variants? Read More »

How effective is the Novavax Covid vaccine and will it work against variants?

Everything you need to know about the trial results for a new coronavirus vaccine Coronavirus – latest updates See all our coronavirus coverage In an interim analysis of a phase 3 clinical trial conducted in the UK, the vaccine has been shown to be nearly 89% effective, with 27% of participants in the trial – …

How effective is the Novavax Covid vaccine and will it work against variants? Read More »

Novavax Covid vaccine shown to be nearly 90% effective in UK trial

UK vaccines taskforce has bought 60m doses after study found ‘spectacular results’ Coronavirus – latest updates See all our coronavirus coverage Another vaccine against Covid, trialled in the UK and bought by the government, has been shown to be nearly 90% effective and work against the UK and South African variants of the virus. The …

Novavax Covid vaccine shown to be nearly 90% effective in UK trial Read More »

AstraZeneca denies pulling out of talks as EU Covid vaccine row deepens

Latest round of crunch talks to discuss breakdown in supplies still happening, says spokesman Coronavirus – latest updates See all our coronavirus coverage A row over coronavirus vaccine shortages in the EU has descended into farce as AstraZeneca denied claims by the European commission that it had pulled out of a crunch meeting over a …

AstraZeneca denies pulling out of talks as EU Covid vaccine row deepens Read More »

Head of AstraZeneca rejects calls for UK vaccine to be diverted to EU

Chief executive of pharmaceutical giant says the firm will honour UK’s earlier contract despite EU anger over shortfall Coronavirus – latest updates See all our coronavirus coverage AstraZeneca’s chief executive has insisted the UK will come first for vaccines as he rejected calls to divert doses to the European Union following a breakdown in supply. …

Head of AstraZeneca rejects calls for UK vaccine to be diverted to EU Read More »

Pharmaceutical giants not ready for next pandemic, report warns

Ten of the world’s most infectious diseases identified by the WHO not being catered for by drug firms The world’s biggest pharmaceutical firms are little prepared for the next pandemic despite a mounting response to the Covid-19 outbreak, an independent report has warned. Jayasree K Iyer, executive director of the Netherlands-based Access to Medicine Foundation, …

Pharmaceutical giants not ready for next pandemic, report warns Read More »

German government challenges AstraZeneca Covid vaccine efficacy reports

Newspaper had reported that government was expecting European regulator’s assessment to show that vaccine was only 8% effective among over-65 The German government has challenged reports of a lower-than-expected efficacy rate of the AstraZeneca vaccine for older people, while reiterating concerns about the British-Swedish pharmaceutical giant’s data reporting. An article in German business daily Handelsblatt …

German government challenges AstraZeneca Covid vaccine efficacy reports Read More »

Germany to administer Covid drugs used to treat Donald Trump

Country will be first in EU to use antibody cocktails after government buys 200,000 doses Specialist clinics in Germany will this week become the first hospitals in the EU to treat Covid-19 patients with expensive and experimental antibody cocktails used to treat the former US president Donald Trump after he caught the virus last October. …

Germany to administer Covid drugs used to treat Donald Trump Read More »

I’ve had my first vaccine jab. It gives me hope of liberation… but not yet

Exactly a year after his first story about coronavirus, our science editor received the Pfizer injection last week. Here he reflects on a remarkable scientific achievement Coronavirus – latest updates See all our coronavirus coverage I marked a grim anniversary in an unexpected manner last week. On 18 January last year, I wrote my first …

I’ve had my first vaccine jab. It gives me hope of liberation… but not yet Read More »

Vaccine experts defend UK decision to delay second Pfizer Covid jab

Medics told they risk undermining public confidence by querying policy of three-month gap between doses Coronavirus – latest updates See all our coronavirus coverage Leading vaccine experts have backed the government’s decision to delay the second dose for up to three months, after doctors warned that the strategy was proving “ever-more difficult to justify”. The …

Vaccine experts defend UK decision to delay second Pfizer Covid jab Read More »

Single Covid vaccine dose in Israel ‘less effective than we hoped’

Surge in infections dampens optimism over country’s advanced immunisation programme Coronavirus – latest updates See all our coronavirus coverage Israel’s coronavirus tsar has warned that a single dose of the Pfizer/BioNtech vaccine may be providing less protection than originally hoped, as the country reported a record 10,000 new Covid infections on Monday. In remarks reported …

Single Covid vaccine dose in Israel ‘less effective than we hoped’ Read More »

Britain could be mass-producing its Covid shot. Shame we junked our industrial base | Aditya Chakrabortty

The dire state of UK manufacturing has left us dependent on other nations. We may soon find out why some call this a ‘national security risk’ Everything now hinges on a vaccine: how many more Britons die, whether the NHS finally breaks, how long the UK stays locked down. All depends on how fast the …

Britain could be mass-producing its Covid shot. Shame we junked our industrial base | Aditya Chakrabortty Read More »

The Oxford Covid jab is delivered this week. But when will vaccines bring results?

Fall or rise in coronavirus cases will not initially be a good measure of efficacy, say scientists devising ways to audit progress Why is Britain delaying second doses of vaccine? Coronavirus – latest updates See all our coronavirus coverage People in Britain are set to get their first shots of the Oxford/AstraZeneca vaccine on Monday, …

The Oxford Covid jab is delivered this week. But when will vaccines bring results? Read More »

Change in vaccine policy is a high-stakes gamble | Letters

The effectiveness of delaying the second dose of Covid vaccines must be carefully monitored, argues Dr Grizelda George, while Jan Mortimer and Jenny van Tinteren fear the move will increase distrust and uncertainty The manufacturer of the Pfizer/BioNTech vaccine has said its efficacy has only been assessed for two doses given three weeks apart. Therefore …

Change in vaccine policy is a high-stakes gamble | Letters Read More »

Questions hang over UK’s rollout of Oxford/AstraZeneca jab

Analysis: regulator surprises by approving 12-week gap between first and second shots of vaccine as well as Pfizer/BioNTech shot Coronavirus – latest updates See all our coronavirus coverage It’s a pragmatic solution to an incredibly urgent problem – how to immunise very large numbers of people at risk from a rampaging variant of Covid-19 in …

Questions hang over UK’s rollout of Oxford/AstraZeneca jab Read More »

UK scientists trial drug to prevent coronavirus infection leading to disease

Exclusive: antibody therapy could confer instant immunity against Covid-19 to at-risk groups See all our coronavirus coverage British scientists are trialling a new drug that could prevent someone who has been exposed to coronavirus from going on to develop the disease Covid-19, which experts say could save many lives. The antibody therapy would confer instant …

UK scientists trial drug to prevent coronavirus infection leading to disease Read More »

British American Tobacco wins approval to test Covid vaccine on humans

Treatment grown on tobacco plants gets US backing for clinical study Coronavirus – latest updates See all our coronavirus coverage British American Tobacco has moved a step closer to producing a vaccine for coronavirus using tobacco plants, as it won approval in the US to begin testing on humans. The company behind cigarette brands including …

British American Tobacco wins approval to test Covid vaccine on humans Read More »

GSK/Sanofi Covid vaccine delayed until end of next year

Trials reveal vaccine failed to produce a strong immune response in older people Coronavirus – latest updates See all our coronavirus coverage A coronavirus vaccine being developed by GlaxoSmithKline and its French partner, Sanofi, will be delayed until the end of next year after trials revealed it failed to produce a strong immune response in …

GSK/Sanofi Covid vaccine delayed until end of next year Read More »

NHS told not to give Pfizer vaccine to extreme allergy sufferers after two people have reaction

Anyone scheduled to receive vaccine will be asked about history of allergic reactions Coronavirus – latest updates See all our coronavirus coverage Regulators have issued a warning that people who have a history of “significant” allergic reactions should not currently receive the Pfizer/BioNTech Covid-19 vaccine after two people who had the jab on Tuesday had …

NHS told not to give Pfizer vaccine to extreme allergy sufferers after two people have reaction Read More »

Nine out of 10 in poor nations to miss out on inoculation as west buys up Covid vaccines

Billions unlikely to get jabs as rich countries secure 53% of most promising vaccines Coronavirus – latest updates See all our coronavirus coverage Nine out of 10 people in 70 low-income countries are unlikely to be vaccinated against Covid-19 next year because the majority of the most promising vaccines coming on-stream have been bought up …

Nine out of 10 in poor nations to miss out on inoculation as west buys up Covid vaccines Read More »

FDA: Pfizer Covid vaccine data fits with guidance on emergency authorization

Comments raise hopes that the vaccine could soon be available to Americans aged 16 and above US Food and Drug Administration (FDA) staff said on Tuesday that data on Pfizer’s coronavirus vaccine was in line with its guidance on emergency use authorization, raising hopes it could soon be available to Americans aged 16 and above. …

FDA: Pfizer Covid vaccine data fits with guidance on emergency authorization Read More »

Covid vaccines offer chance for big pharma to improve its image

They make life-saving medicines, but no one likes them. Could this year be a turning point? Coronavirus – latest updates See all our coronavirus coverage Never before has the world awaited a new medicine with such bated breath. A vaccine for Covid-19 has the potential to unlock society and save millions of people from death …

Covid vaccines offer chance for big pharma to improve its image Read More »

How does the Pfizer/BioNTech vaccine work and who will get it?

Covid vaccine with an efficacy of almost 95% has been authorised by the UK medicines regulator Coronavirus – latest updates See all our coronavirus coverage The Pfizer/BioNTech Covid vaccine, which has an efficacy of almost 95%, has been authorised by the UK medicines regulator, making the UK the first western country to license a vaccine …

How does the Pfizer/BioNTech vaccine work and who will get it? Read More »

Oxford controversy is the first shot in international battle over vaccine efficiency

Trials will not reveal all the facts on prevention for each new drug – that process could last for years Coronavirus – latest updates See all our coronavirus coverage In a few days, researchers plan to solve a medical mystery that threatens to erupt into a major transatlantic battle. Scientists at Oxford University say they …

Oxford controversy is the first shot in international battle over vaccine efficiency Read More »

Different age groups may get different Covid vaccines, experts say

Oxford/AstraZeneca planning new trial of lower-dose jab to see how well it works in older people Coronavirus – latest updates See all our coronavirus coverage Concerns around the efficacy of the Oxford University/AstraZeneca coronavirus jab in older people could lead to different age groups being given different vaccines, experts have said. The partners announced last …

Different age groups may get different Covid vaccines, experts say Read More »

BioNTech’s Covid vaccine is a triumph of innovation and immigration | Hans-Werner Sinn

Pioneered by a Turkish-German couple, its significance exceeds its practical value The world took note when the German startup BioNTech announced its breakthrough in the development of a new type of vaccine to combat Covid-19. After testing tens of thousands of people, BioNTech’s vaccine has been shown to be 95% effective in providing protection for …

BioNTech’s Covid vaccine is a triumph of innovation and immigration | Hans-Werner Sinn Read More »

Will everyone in the world have access to a Covid vaccine? – video explainer

The hunt for a coronavirus vaccine is showing promise but it is premature to say the end of the pandemic is nigh. Several rich countries have signed a ‘frenzy of deals’ that could prevent many poor nations from getting access to immunisation until at least 2024. Also, many drug firms are potentially refusing to waive patents and other intellectual property rights …

Will everyone in the world have access to a Covid vaccine? – video explainer Read More »

A vaccine revolution | podcast

Results from clinical trials have shown that the world has three apparently highly effective vaccines for Covid-19. With the race now on for regulatory approval, production and distribution, is the end of the pandemic within reach? After a gruelling year of successive waves of Covid-19 infections and national lockdowns there has been a burst of …

A vaccine revolution | podcast Read More »

Vaccine results bring us a step closer to ending Covid, says Oxford scientist

Latest breakthrough comes as PM says he hopes most at-risk could be immunised by Easter Coronavirus – latest updates See all our coronavirus coverage The world is moving a step closer to ending the coronavirus pandemic, the scientist behind Britain’s first vaccine has declared, as Boris Johnson said he hoped the majority of those most …

Vaccine results bring us a step closer to ending Covid, says Oxford scientist Read More »

Oxford AstraZeneca results open up Covid vaccine to developing countries

Jab can be kept in fridge and is part of global initiative to distribute doses at limited cost Coronavirus – latest updates See all our coronavirus coverage The efficacy of the Oxford University/AstraZeneca vaccine opens the way for a cheap and more easily transportable vaccine to be made available to some of the world’s poorest …

Oxford AstraZeneca results open up Covid vaccine to developing countries Read More »

The Guardian view on coronavirus and vaccine scepticism: time to act | Editorial

Plans for mass immunisation against Covid-19 are developing fast, but concerns must be addressed In the 1960s, academics studying rumours drew inspiration from epidemiology. They noted how such stories spread through communities, “infecting” some individuals while others seemed immune, and how more resistant populations could stop their spread. Their insights have in turn been taken …

The Guardian view on coronavirus and vaccine scepticism: time to act | Editorial Read More »

Do mRNA vaccines for Covid signal a new era in disease prevention? | Adam Finn

No one knew whether mRNA technology would work against this virus – but it does. It’s an extraordinary moment for science Coronavirus – latest updates See all our coronavirus coverage The past few months have brought a number of scientific terms to public attention. We’ve had to digest R (a virus’s reproduction number) and PCR …

Do mRNA vaccines for Covid signal a new era in disease prevention? | Adam Finn Read More »

Trials to begin in UK for Covid antibody cocktail drug treatment

Scientists say jab could be used to protect those who cannot be given vaccines Coronavirus – latest updates See all our coronavirus coverage Major trials will begin this weekend of an antibody cocktail that scientists hope will protect people against Covid-19 and could be swiftly used in care homes or on cruise ships in the …

Trials to begin in UK for Covid antibody cocktail drug treatment Read More »

UK faces calls to drop opposition to patent-free Covid vaccines

Request will be made at WTO meeting in order to allow mass production of treatments Coronavirus – latest updates See all our coronavirus coverage The UK will be asked to reconsider its opposition to waiving intellectual property rights for Covid-19 vaccines and treatments at a World Trade Organization meeting on Friday, a move that would …

UK faces calls to drop opposition to patent-free Covid vaccines Read More »

Pfizer Covid-19 vaccine has 95% efficacy and is safe, further analysis shows

Among first 170 Covid cases in trial, eight had received vaccine and 162 were in placebo group Coronavirus – latest updates See all our coronavirus coverage The Pfizer/BioNTech vaccine against Covid-19 performs even better than previously thought, with 95% efficacy, equalling the early results from Moderna on Monday, according to an analysis of the final …

Pfizer Covid-19 vaccine has 95% efficacy and is safe, further analysis shows Read More »

UK in ‘advanced discussions’ to buy Moderna Covid vaccine

Britain decided not to buy US vaccine and earliest it could be supplied to UK is spring 2021 Coronavirus – latest updates See all our coronavirus coverage The UK has not acquired the Moderna vaccine but is in “advanced discussions” to ensure British access, officials have said, while cautioning that no one in the UK …

UK in ‘advanced discussions’ to buy Moderna Covid vaccine Read More »

It’s the ‘vaccine hesitant’, not anti-vaxxers, who are troubling public health experts | Gaby Hinsliff

To make vaccination work, we must reach out to the naturally cautious – a bigger proportion than you might assume Coronavirus – latest updates See all our coronavirus coverage Lydia Guthrie is not very daring by nature. A psychotherapist and mother of two from Oxford, she couldn’t be persuaded into bungee jumping for all the …

It’s the ‘vaccine hesitant’, not anti-vaxxers, who are troubling public health experts | Gaby Hinsliff Read More »

BioNTech vaccine scientist says jab could halve Covid transmission

Uğur Şahin ‘very confident’ vaccine candidate developed with Pfizer will cause big reduction in cases Coronavirus – latest updates See all our coronavirus coverage The scientist behind the first potential Covid-19 vaccine to clear interim clinical trials says he is “very confident” the jab will reduce transmission of the disease, perhaps by 50%, resulting in …

BioNTech vaccine scientist says jab could halve Covid transmission Read More »

Vaccination hesitancy is about lack of trust. Compulsion is not the answer | Kenan Malik

Better to build social solidarity than to dismiss reluctance to be immunised as ignorance Coronavirus – latest updates See all our coronavirus coverage “If a strain as deadly as the 1918 influenza emerges and people’s hesitancy to get vaccinated remains at the level it is today, a debilitating and fatal disease will spread.” So wrote …

Vaccination hesitancy is about lack of trust. Compulsion is not the answer | Kenan Malik Read More »

BioNTech chief rejects Trump claim it delayed Covid vaccine news

Exclusive: Ugur Şahin says he and Pfizer CEO received results night before announcement Coronavirus – latest updates See all our coronavirus coverage The scientist behind the BioNTech/Pfizer coronavirus vaccine has defended his company from Donald Trump’s accusation that it deliberately delayed news of its rapid progress until after the election, saying “we don’t play politics”. …

BioNTech chief rejects Trump claim it delayed Covid vaccine news Read More »

The Covid vaccine will benefit humanity – we should all own the patent | Owen Jones

The pharmaceutical industry has long made exorbitant profits by free-riding on research carried out by the public sector Hooray for Pfizer! As news of a vaccine potentially offering 90% protection against Covid-19 offers a life raft for lockdown-weary humanity, perhaps those home-drawn posters on people’s windows thanking the NHS will soon be applauding big pharma …

The Covid vaccine will benefit humanity – we should all own the patent | Owen Jones Read More »

Why a Covid vaccine doesn’t mean the end of face masks yet | David Salisbury

Despite the Pfizer breakthrough, social distancing and remote working won’t disappear overnight Coronavirus – latest updates See all our coronavirus coverage The news this week that the Pfizer/BioNTech vaccine protected more than 90% of recipients is of huge importance. The vaccine efficacy is higher than we had hoped for. There appear to be no safety …

Why a Covid vaccine doesn’t mean the end of face masks yet | David Salisbury Read More »

Where will poorer countries stand in the queue for a Covid-19 vaccine? | Clare Wenham and Mark Eccleston-Turner

The lion’s share of the potential Pfizer vaccine is already claimed by high-income nations The news that joint efforts by the US pharmaceutical company Pfizer and the German biotech company BioNtech have produced a vaccine that is 90% effective at protecting people from Covid-19 has been understandably applauded – in spite of the caveats. Pfizer …

Where will poorer countries stand in the queue for a Covid-19 vaccine? | Clare Wenham and Mark Eccleston-Turner Read More »

FTSE 100 recovers to highest level since June after vaccine unveiled

Promising clinical data from Pfizer and BioNTech help the index to a £28bn one-day gain Optimism that a mass rollout of Covid-19 vaccines will lead to an economic recovery lifted stocks in London again on Tuesday, to their highest closing level in over four months. London’s FTSE 100 index of blue-chip shares rallied by nearly …

FTSE 100 recovers to highest level since June after vaccine unveiled Read More »

Pfizer and BioNTech’s vaccine poses global logistics challenge

Europe and US create vast facilities for Covid-19 vaccine but poorer nations lack infrastructure say experts Coronavirus – latest updates See all our coronavirus coverage Two vast football-pitch-sized facilities equipped with hundreds of large freezers in Kalamazoo, Michigan, and Puurs, Belgium, will be the centres of the huge effort to ship the coronavirus vaccine developed …

Pfizer and BioNTech’s vaccine poses global logistics challenge Read More »

The Guardian view on the Covid vaccine breakthrough: making it work | Editorial

At last, there is hope of an end to this pandemic. Scientists appear to have performed an amazing feat, the rest of us must do our best too Medicine is only partly a matter of science; it is, very much, the business of people. The inspiring news that a Covid vaccine appears within reach, with …

The Guardian view on the Covid vaccine breakthrough: making it work | Editorial Read More »

Will enough people in the UK take the Covid-19 jab?

The UK usually has a high take-up for vaccines, experts say, but there are fears over misinformation and scepticism Coronavirus: anti-vaxxers seek to discredit Pfizer’s vaccine Coronavirus – latest updates See all our coronavirus coverage The spread of scepticism and misinformation about coronavirus and the development of a vaccine for it has raised questions about …

Will enough people in the UK take the Covid-19 jab? Read More »

Cautious optimism over Covid-19 vaccine trials | Letters

Readers respond to news that an interim analysis has shown Pfizer/BioNTech’s vaccine candidate was 90% effective in protecting people from transmission of the virus in global trials The media have been awash with stories about the apparent success of the Pfizer Covid vaccine following the publication of preliminary trial outcomes (Hopes rise for end of …

Cautious optimism over Covid-19 vaccine trials | Letters Read More »

6 key questions about the Pfizer/BioNTech Covid-19 vaccine

There are grounds for optimism but also several unknowns around this coronavirus vaccine Coronavirus – latest updates See all our coronavirus coverage Hopes that the end of the coronavirus pandemic has become nearer have soared after the news that a coronavirus vaccine was found to be 90% effective in global trials. Although there is definite …

6 key questions about the Pfizer/BioNTech Covid-19 vaccine Read More »

Despite the fine print, we can still feel optimistic about a Covid vaccine | Charlotte Summers

Pfizer’s preliminary results are a huge development, although hurdles still lie ahead Dr Charlotte Summers is a lecturer in intensive care medicine at the University of Cambridge Coronavirus – latest updates We could all do with some good news right now. After a long and difficult year of multiple lockdowns and numerous sacrifices, the announcement …

Despite the fine print, we can still feel optimistic about a Covid vaccine | Charlotte Summers Read More »

What does the Pfizer Covid vaccine breakthrough mean for Australia?

Interim results show vaccine to be 90% effective, but findings have not been peer-reviewed, Australia has only secured enough for five million people, and there are concerns around its storage temperature • Pfizer says vaccine is 90% effective • What has Pfizer’s vaccine trial found? • Vaccine announcement is cause for cautious celebration News that …

What does the Pfizer Covid vaccine breakthrough mean for Australia? Read More »

What has Pfizer’s Covid vaccine trial found and is this a breakthrough?

Early results from phase 3 trial look promising but there are still many questions to be answered Coronavirus – latest updates See all our coronavirus coverage Pfizer and the German biotech company Biontech said on Monday that they had had encouraging early results from a phase 3 clinical trial of their coronavirus vaccine. The trial …

What has Pfizer’s Covid vaccine trial found and is this a breakthrough? Read More »

NHS coronavirus tests threatened by Roche supply chain glitch

Pharmaceutical firm reports ‘significant drop in processing capacity’ of reagents, kits and swabs Coronavirus – latest updates See all our coronavirus coverage Concerns have been raised over the supply of vital testing materials for a range of conditions, including Covid-19, following a supply chain problem with the pharmaceutical company Roche. On Tuesday, Roche said it …

NHS coronavirus tests threatened by Roche supply chain glitch Read More »

Trump’s steroid Covid treatment adds to confusion over health

Dexamethasone ‘normally reserved for people going into respiratory failure’, says expert Trump coronavirus treatment – live updates The latest intervention from Donald Trump’s medical team has been to put the president on dexamethasone, a steroid that is proven, thanks to the UK’s Recovery trial, to benefit Covid-19 patients who are having breathing difficulties. But the …

Trump’s steroid Covid treatment adds to confusion over health Read More »

Anti-Covid treatments being given to Trump are still unproven, say experts

Neither remdesivir nor REGN-COV2 have completed large-scale randomised trials, say UK scientists Coronavirus – latest updates See all our coronavirus coverage Scientists still lack conclusive proof that the two anti-Covid drugs given to Donald Trump are clinically effective. UK researchers point out that both medicines – remdesivir and REGN-COV2 – have still to complete the …

Anti-Covid treatments being given to Trump are still unproven, say experts Read More »

UK doing more than most to help poor get Covid vaccine, study finds

Campaign scoring countries for global access efforts calls for more British transparency Coronavirus – latest updates See all our coronavirus coverage The UK is doing more than most countries to support access to Covid vaccines for the poorest populations in the world, but it is not transparent enough about the deals it is doing at …

UK doing more than most to help poor get Covid vaccine, study finds Read More »

Show more empathy to boost confidence in vaccines, scientists told

Expert behind vaccine confidence report points to halting of Oxford Covid trial as example Doctors and scientists need to show more empathy towards volunteers in coronavirus vaccine trials who fall ill if the public is to have full confidence in the safety of the vaccines being developed, say experts. The temporary halting of the Oxford …

Show more empathy to boost confidence in vaccines, scientists told Read More »

Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief

Pharmaceutical firm’s boss says 2020 deadline possible if regulators move fast Coronavirus – latest updates See all our coronavirus coverage AstraZeneca’s coronavirus vaccine could still be available by the end of the year, or early next year, according to the company’s chief executive, Pascal Soriot, despite clinical trials being paused after a volunteer fell ill. …

Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief Read More »

Oxford Covid vaccine trial suspension: what happens next?

Tests have been paused after a UK volunteer became ill. How will it affect the search for a cure? The AstraZeneca vaccine trial has been paused – should we be worried? Coronavirus – latest updates See all our coronavirus coverage One of the volunteers in the UK has become ill and it is crucial that …

Oxford Covid vaccine trial suspension: what happens next? Read More »

The Oxford University AstraZeneca Covid-19 vaccine trial has been paused – should we be worried?

Is this the end for hopes of an early breakthrough in the race to find a coronavirus drug? The halt in development of the University of Oxford’s Covid-19 vaccine due to a possible adverse reaction in a trial participant has triggered fears of a delay in finding a solution to coronavirus restrictions. A spokesman for …

The Oxford University AstraZeneca Covid-19 vaccine trial has been paused – should we be worried? Read More »

Oxford University Covid vaccine trial put on hold due to possible adverse reaction in participant

A spokesman for AstraZeneca, the company working on the coronavirus vaccine, said pausing trials was common during vaccine development The development of a promising Covid-19 vaccine has been put on hold due to a possible adverse reaction in a trial participant. A spokesman for AstraZeneca, the company working with a team from Oxford University, told …

Oxford University Covid vaccine trial put on hold due to possible adverse reaction in participant Read More »

Six of the most promising treatments for Covid-19 so far

While a cure-all drug or therapy is a long way off, there have been some breakthroughs Many different drugs and therapies are being trialled and used on patients with Covid-19. There are some positive results, which may be beginning to bring the hospital death toll down, but there is still a long way to go …

Six of the most promising treatments for Covid-19 so far Read More »

Oxford University Covid-19 vaccine firm denies Trump talks

AstraZeneca says it has not discussed ‘emergency use authorisation’ with the US Coronavirus – latest updates See all our coronavirus coverage The company manufacturing the Oxford University coronavirus vaccine has denied it is in talks with the Trump administration about fast-tracking its vaccine for emergency use ahead of November’s presidential elections. With both Russia and …

Oxford University Covid-19 vaccine firm denies Trump talks Read More »

Here’s everything you need to know about the potential Oxford University Covid vaccine

The vaccine is designed to mimic the coronavirus and train the immune system to react if a person is later infected Sign up for Guardian Australia’s coronavirus email Download the free Guardian app to get the most important news notifications The vaccine developed and tested by a team at Oxford University is one of the …

Here’s everything you need to know about the potential Oxford University Covid vaccine Read More »

UK agrees deals for 90m doses of two potential coronavirus vaccines

Government secures early access to those being developed by Novavax and Janssen Coronavirus – latest updates See all our coronavirus coverage The UK government has reached agreements it says will give British citizens early access to 90m doses of two more potential Covid-19 vaccines. The vaccines are being developed by the US biotech company Novavax …

UK agrees deals for 90m doses of two potential coronavirus vaccines Read More »

The Guardian view on Brexit bureaucracy: tied up in red tape | Editorial

Businesses already struggling with the fallout from Covid-19 will be forced to deal with a mountain of new bureaucracy in the middle of a deep recession The government did not quite achieve the Brexit breakthrough it was seeking on Friday, when there was hope that a fast-tracked trade agreement with Japan might be reached. But …

The Guardian view on Brexit bureaucracy: tied up in red tape | Editorial Read More »

Coronavirus: UK signs deal for 60m doses of potential vaccine

GlaxoSmithKline and Sanofi Pasteur could supply vaccine by early next year if it is successful Coronavirus – latest updates See all our coronavirus coverage The government has signed a deal with the pharmaceutical firms GlaxoSmithKline (GSK) and Sanofi Pasteur for 60m doses of a potential Covid-19 vaccine. If the vaccine proves successful, the UK could …

Coronavirus: UK signs deal for 60m doses of potential vaccine Read More »

AstraZeneca signs deal worth up to £4.7bn for cancer treatment

Pharmaceuticals company buys global rights to new technology from Japan’s Daiichi Sankyo Drugmaker AstraZeneca could pay up to $6bn (£4.7bn) for the global rights to a new Japanese cancer treatment. The Anglo-Swedish pharmaceutical company said it would pay $1bn (£800m) up front to its partner Daiichi Sankyo. Related: Covid-19 is Big Pharma’s chance to impress. …

AstraZeneca signs deal worth up to £4.7bn for cancer treatment Read More »

‘Major’ breakthrough in Covid-19 drug makes UK professors millionaires

Synairgen’s share price rises 540% on morning of news of successful drugs trial Coronavirus – latest updates See all our coronavirus coverage Three professors at the University of Southampton school of medicine have this week made a “major breakthrough” in the treatment of coronavirus patients and become paper millionaires at the same time. Almost two …

‘Major’ breakthrough in Covid-19 drug makes UK professors millionaires Read More »

The world needs a ‘people’s vaccine’ for coronavirus, not a big-pharma monopoly | Helen Clark and Winnie Byanyima

AstraZeneca and others should not own a lucrative patent on a medicine that is needed by poor as well as rich nations • See all our coronavirus coverage • Helen Clark is a former prime minister of New Zealand and Winnie Byanyima is UN undersecretary general To bring an end to the pandemic, the world …

The world needs a ‘people’s vaccine’ for coronavirus, not a big-pharma monopoly | Helen Clark and Winnie Byanyima Read More »

UK ‘95% sure’ Russian hackers tried to steal coronavirus vaccine research

Minister says Britain and allies confident Russian intelligence was behind cyber-attacks Coronavirus – latest updates See all our coronavirus coverage The UK security minister James Brokenshire has said Britain is “more than 95%” sure that Russian state-sponsored hackers targeted UK, US and Canadian organisations involved in developing a coronavirus vaccine. Brokenshire said the National Cyber …

UK ‘95% sure’ Russian hackers tried to steal coronavirus vaccine research Read More »

WHO says trials show malaria and HIV drugs don’t cut Covid-19 hospital deaths

Hydroxychloroquine and lopinavir/ritonavir not found to help patients in hospital Coronavirus – latest updates See all our coronavirus coverage The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir for patients in hospital with Covid-19 after they failed to reduce mortality. …

WHO says trials show malaria and HIV drugs don’t cut Covid-19 hospital deaths

Read More »

Oxford offers best hope for Covid-19 vaccine this year, MPs told

University is leading rivals but first drugs may not work fully, says vaccine taskforce chair Coronavirus – latest updates See all our coronavirus coverage Oxford University is leading the world in developing a vaccine against Covid-19 and offers the best chance of having something protective against the virus as we go into winter, MPs have …

Oxford offers best hope for Covid-19 vaccine this year, MPs told Read More »

‘The wondrous map’: how unlocking human DNA changed the course of science

Thanks to the success of the Human Genome Project, 20 years ago this week, scientists can track biology and disease at a molecular level Twenty years ago this week, an international group of scientists announced it had put together the first genetic blueprint of a human being. After 10 years of effort, the team – …

‘The wondrous map’: how unlocking human DNA changed the course of science Read More »

The Lancet’s editor: ‘The UK’s response to coronavirus is the greatest science policy failure for a generation’

Richard Horton does not hold back in his criticism of the UK’s response to the pandemic and the medical establishment’s part in backing fatal government decisions Coronavirus – latest updates See all our coronavirus coverage There is a school of thought that says now is not the time to criticise the government and its scientific …

The Lancet’s editor: ‘The UK’s response to coronavirus is the greatest science policy failure for a generation’

Read More »